← DocGo Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Revenues, net | $94.1m | $318.7m | $440.5m | $624.3m | $616.6m | $322.2m | $301.7m | |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) | $62.7m |
$209.0m
+233.06%
|
$285.8m
+36.76%
|
$428.9m
+50.08%
|
$403.0m
-6.04%
|
$223.4m
-44.55%
|
$209.9m
-6.05%
|
|
| Technology and development | $1.2m | $3.3m | $5.4m | $10.9m | $11.6m | $13.6m | — | |
| General and administrative | $34.9m | $74.9m | $103.4m | $137.2m | $138.8m | $133.4m | $156.0m | |
| Loss on equity method investments | — | — | — | ($343k) | ($316k) | ($553k) | — | |
| Total other expense (income) | — | ($40k) | ($987k) | $1.2m | ($940k) | ($9.5m) | — | |
| Net (loss) income before income tax expense | ($14.6m) | $19.8m | $22.8m | $16.3m | $27.7m | ($187.5m) | — | |
| Provision for income taxes | — | ($616k) | $8.0m | ($6.2m) | ($14.4m) | ($8.9m) | — | |
| Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share) | ($0) | $0 | $0 | $0 | $0 | ($2) | — | |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share) | ($0) | $0 | $0 | $0 | $0 | ($2) | — | |
| Weighted-average shares outstanding - Basic (in Shares) | 58.4m | 80.3m | 101.2m | 103.5m | 102.4m | 99.1m | — | |
| Weighted-average shares outstanding - Diluted (in Shares) | 58.4m | 94.9m | 103.0m | 105.6m | 109.4m | 99.1m | — | |
| Depreciation and amortization | $5.5m | $7.5m | $10.6m | $16.4m | $15.9m | $15.7m | $14.5m | |
| Legal and regulatory | $3.7m | $3.9m | $8.8m | $13.1m | $17.1m | $23.8m | — | |
| Sales, advertising and marketing | $746k | $4.8m | $4.8m | $2.8m | $1.5m | $1.4m | — | |
| Intangible asset impairment | — | — | — | $0 | $0 | $30.6m | — | |
| Goodwill impairment | — | $0 | ($2.9m) | $0 | $0 | $58.2m | $88.9m | |
| (Loss) income from operations | ($169k) | $15.4m | $21.8m | $15.1m | $28.7m | ($178.0m) | — | |
| Interest (expense) income, net | — | — | $763k | $1.7m | ($1.9m) | ($1.2m) | $1.9m | |
| (Loss) gain on change in fair value of contingent consideration | — | $0 | $0 | $1.4m | $9.4m | ($2.1m) | — | |
| Finite-lived intangible asset impairment | — | — | $0 | $0 | ($8.3m) | $0 | — | |
| Equity investment impairment | — | — | — | $0 | $0 | ($5.0m) | — | |
| Loss on remeasurement of operating and finance leases | — | $0 | $1.4m | ($866) | ($32k) | ($42k) | — | |
| (Loss) gain on disposal of assets | — | ($34k) | ($21k) | ($853k) | $24k | ($40k) | — | |
| Other (expense) income | $300k | ($40k) | ($987k) | ($687k) | $229k | ($532k) | — | |
| Net (loss) income | — | $19.2m | $30.7m | $10.0m | $13.4m | ($196.4m) | — | |
| Net (loss) income attributable to noncontrolling interests | ($439k) | ($4.6m) | ($3.8m) | $3.2m | ($6.6m) | ($14.0m) | — | |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries | ($149k) | $23.7m | $34.6m | $6.9m | $20.0m | ($182.4m) | — | |
| Unrealized gain on investments, net of tax | — | — | — | $0 | $0 | $86k | — | |
| Foreign currency translation adjustment | $196k | $16k | $774k | $744k | ($263k) | $1.1m | — | |
| Total expenses | $108.8m | $303.4m | $418.7m | $609.2m | $587.9m | $500.2m | $395.6m | |
| Total comprehensive (loss) income | ($14.2m) | $23.8m | $35.4m | $7.6m | $19.7m | ($181.2m) | — |